New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 17, 2014
06:23 EDTQUREuniQure and Chiesi announce six year follow-up data from Glybera
uniQure and Chiesi Farmaceutici announced initial analysis of retrospectively collected individual patient data from LPLD patients treated with Glybera. The analysis covers follow-up data for up to six years post treatment for 13 patients, all of whom met indication requirements for the current labeling of Glybera in the EU. The review suggests that treatment with Glybera provides long-term beneficial effects with regard to the risk of encountering new pancreatitis events, including the occurrence of severe pancreatitis events. These results are in line with the trend exhibited in the first case note review performed up to 3 years after treatment with Glybera.
News For QURE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 28, 2014
08:46 EDTQUREbluebird bio drug has pricing upside after Glybera, says Roth Capital
Subscribe for More Information
06:54 EDTQUREuniQure partner prices Glybera at $1.4M in Germany, says Piper Jaffray
Subscribe for More Information
November 26, 2014
13:47 EDTQUREuniQure gene therapy drug to have record setting price tag, Reuters says
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use